Position in RGNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$756,249
+$327,788 QoQ
Shares Held
63,126
+23.5% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 163 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. RGNX ranks #183 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in RGNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $756,249 | 63,126 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $428,461 | 51,129 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $561,528 | 38,995 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $376,272 | 38,992 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $229,715 | 27,980 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $187,330 | 26,200 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $184,824 | 23,910 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $230,024 | 21,928 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $246,870 | 21,100 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $382,989 | 18,177 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $300,465 | 16,739 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $256,644 | 15,592 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $288,815 | 14,448 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $264,021 | 13,962 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,908,012 | 172,311 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,842,404 | 221,052 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,431,678 | 219,906 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,301,383 | 250,117 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,243,471 | 313,256 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,364,094 | 294,945 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,886,430 | 280,217 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,046,998 | 294,547 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $13,101,600 | 288,836 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,201,400 | 298,016 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $11,651,096 | 316,348 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $11,434,802 | 353,144 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||